Cancer Research UK says some sufferers with uncommon cancers are struggling to get entry to experimental medicine even when their medical doctors wish to use them.
The organisation stated extra individuals had been looking for non-public care. Our Health Editor Hugh Pym has been talking to 1 affected person whose non-public insurer is not going to pay for a drug which could assist her.
AXA PPP Healthcare has stated that the drug in query just isn’t licensed or accepted by NICE (National Institute for Health and Care Excellence). The firm added that it was persevering with to fund different remedy.
Produced by Dominic Hurst. Video Journalist Harriet Bradshaw